MedTrace Logo

Genetic Susceptibility to Rheumatic Heart Disease in the Pacific Region

NCT02188862 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2372

Last updated 2014-07-15

No results posted yet for this study

Summary

The purpose of this study is to investigate whether there are genetic differences between patients with rheumatic heart disease and members of the general population.

Conditions

  • Rheumatic Heart Disease
  • Mitral Stenosis

Sponsors & Collaborators

  • Ministry of Health, Fiji

    collaborator OTHER_GOV

  • Fiji National University

    collaborator OTHER

  • Institut National de la Santé Et de la Recherche Médicale, France

    collaborator OTHER_GOV

  • Institut Necker Enfants Malades

    collaborator OTHER

  • Centre Hospitalier Territorial de Nouvelle-Calédonie

    collaborator OTHER

  • University of Melbourne

    collaborator OTHER

  • University of Oxford

    lead OTHER

Principal Investigators

  • Tom Parks, MRCP DTM&H · University of Oxford

  • Mariana Mirabel, MD · Institut National de la Santé Et de la Recherche Médicale, France

  • Andrew C Steer, FRACP PhD · University of Melbourne

  • Adrian VS Hill, DPhil DM · University of Oxford

Eligibility

Min Age
5 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-09-30
Primary Completion
2013-12-31
Completion
2013-12-31

Countries

  • Fiji
  • New Caledonia
  • United Kingdom

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02188862 on ClinicalTrials.gov